Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3981-3990 of 4090 results

Catalogue Number:

PX-TA1182

Category:

G

Tucotuzumab Biosimilar – Anti-EPCAM/ CD326 mAb – Research Grade

Target: EPCAM/ CD326
Target Alias Name: Tucotuzumab/EMD 273066/KSA-Interleukin-2/huKS-IL2/huKS1/4-IL-2/EPCAM/ CD326/anti-EPCAM/ CD326
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2090

Category:

G

Tulisokibart Biosimilar – Anti-TNFSF15 mAb – Research Grade

Target: TNFSF15
Target Alias Name: anti-TNFSF15/ Vascular endothelial cell growth inhibitor/ VEGI/ TL1/ TNF ligand-related molecule 1/ Tumor necrosis factor ligand superfamily member 15
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2091

Category:

G

Tuparstobart Biosimilar – Anti-FDC mAb – Research Grade

Target: FDC
Target Alias Name: anti-FDC/ LAG3/ Lymphocyte activation gene 3 protein/ CD223/ sLAG-3/ LAG-3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1729

Category:

G

Tusamitamab Biosimilar – Anti-CEACAM5 mAb – Research Grade

Target: CEACAM5
Target Alias Name: Tusamitamab/IMMUNOGLOBULIN G1 (DE-450-LYSINE)/ ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL SAR408377 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SAR408377 .KAPPA.-CHAIN/ DIMER/ IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENS CEACAM5 (CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5/ CEA/ CD66E))/ MONOCLONAL ANTIBODY/CEACAM5/anti-CEACAM5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1124

Category:

G

Tuvirumab Biosimilar – Anti-HBV mAb – Research Grade

Target: HBV
Target Alias Name: Tuvirumab/anti-hepatitis B/HBV/anti-HBV
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1781

Category:

G

Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade

Target: CTLA4
Target Alias Name: Tuvonralimab/PBS-105/ PBS105/ PSB-205/ QL1706/CTLA4/anti-CTLA4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1756

Category:

G

Ubamatamab Biosimilar – Anti-MUC16 & CD3e mAb – Research Grade

Target: MUC16 & CD3e
Target Alias Name: Ubamatamab/REGN4018/MUC16 & CD3e/anti-MUC16 & CD3e
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1264

Category:

G

Ublituximab Biosimilar – Anti-MS4A1/ CD20 mAb – Research Grade

Target: MS4A1/ CD20
Target Alias Name: Ublituximab/LFB-R603/ TG-1101/TGTX-1101/MS4A1/ CD20/anti-MS4A1/ CD20
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2144

Category:

G

Ucenprubart Biosimilar – Anti-MOX2R mAb – Research Grade

Target: MOX2R
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1773

Category:

G

Ulenistamab Biosimilar – Anti-PAUF mAb – Research Grade

Target: PAUF
Target Alias Name: Ulenistamab/PBP 1510/ PBP-1510/ PBP1510/PAUF/anti-PAUF
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression